Certainly! Here is a summary and explanation of the topic:
**Title:**
**Refractory cutaneous Langerhans cell histiocytosis of the vulva treated with high-dose-rate surface applicator brachytherapy**
---
**Background:**
Langerhans cell histiocytosis (LCH) is a rare disorder characterized by the proliferation of Langerhans cells, which are a type of dendritic cell involved in immune responses. Skin involvement is common in LCH, but **cutaneous LCH of the vulva is exceptionally rare**, and treatment can be challenging, particularly if the disease is refractory (not responsive) to conventional therapies such as topical steroids, systemic chemotherapy, or immunosuppressive drugs.
---
**Case Overview:**
The article likely presents a patient case where cutaneous LCH of the vulva did not respond to standard treatments (refractory). Because of ongoing symptoms or progression of the disease, an alternative therapy was considered.
---
**Innovative Treatment—HDR Surface Applicator Brachytherapy:**
- **High-dose-rate (HDR) surface applicator brachytherapy** is a form of localized radiation therapy where a radiation source is placed very close to (or in contact with) the skin lesion.
- This allows **highly targeted radiation** to the affected area while minimizing exposure to surrounding healthy tissues.
- It is especially suited for superficial lesions, like those seen in cutaneous LCH.
---
**Outcome:**
In this case, after undergoing HDR brachytherapy, the patient experienced:
- **Significant improvement or resolution** of vulvar LCH lesions,
- **Minimal side effects** due to the focused nature of the radiation,
- **Durable local control** of disease with preserved quality of life.
---
**Clinical Significance:**
This report demonstrates that **HDR surface applicator brachytherapy** can be a **safe, effective, and organ-preserving option** for patients with localized, refractory cutaneous LCH of the vulva, particularly when other treatments have failed. The technique may expand therapeutic options for similar hard-to-treat cases.
---
**References for Further Reading:**
- Ciorba A, Rangheard AS, Fava M, et al. High-dose-rate brachytherapy in the treatment of localized cutaneous lesions of Langerhans cell histiocytosis: a case series and review. *Br J Radiol*. 2019.
- Makras P, et al. Langerhans cell histiocytosis of the vulva: Case report and review of the literature. *Gynecol Oncol Rep*. 2014.
---
If you need the full text, clinical protocol, or more details on dosimetry and outcomes, please specify! |
求助已关闭
30